Background Countries around the world are currently aiming to improve patient safety by means of Institute for Healthcare Improvement global trigger tool (GTT), which is considered a valid evaluating and measuring within organisations. So far, only few data on measurement properties utility GTT have been published. Aims To determine evaluate effect interrater variation between review teams standard outcome measures assess quantify error GTT. Methods Retrospective chart reviews were conducted...

Objective.To determine any additional value in the evaluation of safety levels by adding an appended oncology module to Institute for Healthcare Improvement's Global Trigger Tool (GTT).Design.Comparison two independent retrospective chart reviews: one review team using general GTT method and plus on same inpatient charts.Setting.

Background: Procedure codes in the Danish National Patient Registry are used for administrative purposes and a potentially valuable resource epidemiologic research. To our knowledge, validity of antineoplastic procedure has only been evaluated one study. Methods: We randomly extracted sample 420 patients Southern Region Denmark with diagnosis colorectal cancer an oncology contact during 2016–2018. Using medical record as gold standard, we computed positive predictive value (PPV) sensitivity...

Oncology clinicians readily accepted features designed to enhance oral chemotherapy safety. Additional enhancements are needed facilitate prescriptions with complex dosing regimens.

Anticancer treatments near the end of a patient's life should generally be avoided, as it leaves patient with no significant anticancer effect but increases risk severe side effects. We described pattern all end-of-life treatment in population Danish cancer patients.Using national health registries, we identified patients deceased due to 2010-2015. registered last 30 days was categorized treatment. Predictors such were investigated using logistic regression models.We 42,277 (median age 70...

The Region of Southern Denmark has recently established four late effects clinics to help cancer survivors suffering from complex and severe effects. This study aimed capture analyze the full range physical, mental, psychosocial issues using patient-reported outcomes. Moreover, we describe demographic data type severity

Objective Patients in anticancer treatment with a known side effect of neutropenia are monitored closely laboratory measurements white blood cell count (WBC) and differentiation. This study sought to evaluate measurement properties feasibility patients' self-testing using point-of-care testing (POCT) device. Methods A prospective comparing the standard cancer WBC neutrophil POCT measurements. The included 60 outpatients 22 inpatients from department oncology at university hospital. Results...

Objectives: To identify risks associated with delivery of treatment oral antineoplastic agents in an outpatient setting and to evaluate additional value feasibility engaging patients a proactive risk analysis. Methods: We conducted 2 separate but parallel failure mode effects analyses (FMEAs) among health care professionals (HCPs) at clinical oncology department Denmark. Comparative were performed using the FMEA process maps priority numbers (RPNs) as main outcome measures. The FMEAs...

Abstract Purpose This study aims to investigate changes in employment status among disease-free working-age cancer survivors (CSs) with late effects from diagnosis their first meeting the Late Effects Clinic (LEC) and associated patient-reported outcomes of reduced status. Methods Retrospective analysis a cohort CSs followed LEC at single institution January, 2022, March, 2023. Working-age no current evidence active were included this study. completed baseline questionnaire (EORTC...

6614 Background: The prevalence of non-intercepted prescribing errors and the impact computerized order entry systems (CPOE) in preventing such are not known. Our objective was to evaluate both severity prescription dose as well a CPOE system on these setting adult cancer patients. Methods: A prospective observational case control study two clinical oncology units. One institution used parallel with no connection electronic patient chart data, while other paper based forms. All standard...

235 Background: The Institute for Healthcare Improvement developed the Global Trigger Tool (GTT) measuring harm rates over time in 2006. Few studies have been published on measurement properties of GTT and no assessed value adding specific modules to generic GTT. We, therefore, aimed determine inter-rater reliability, evaluate effect interrater variation reliability detect adverse event time. Furthermore an oncology module number category events (AEs) identified. Methods: A retrospective...